BR9710901A - M-todo para o tratamento da doen-a bipolar - Google Patents
M-todo para o tratamento da doen-a bipolarInfo
- Publication number
- BR9710901A BR9710901A BR9710901A BR9710901A BR9710901A BR 9710901 A BR9710901 A BR 9710901A BR 9710901 A BR9710901 A BR 9710901A BR 9710901 A BR9710901 A BR 9710901A BR 9710901 A BR9710901 A BR 9710901A
- Authority
- BR
- Brazil
- Prior art keywords
- bipolar disorder
- todo
- treatment
- humans
- chem
- Prior art date
Links
- 208000020925 Bipolar disease Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
- Electrolytic Production Of Non-Metals, Compounds, Apparatuses Therefor (AREA)
- Medicines Containing Plant Substances (AREA)
- Steroid Compounds (AREA)
- Nonmetallic Welding Materials (AREA)
- Press Drives And Press Lines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Processing Of Solid Wastes (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2290096P | 1996-08-01 | 1996-08-01 | |
| PCT/US1997/013185 WO1998005324A1 (en) | 1996-08-01 | 1997-07-28 | Method for treating bipolar disorder |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9710901A true BR9710901A (pt) | 1999-08-17 |
Family
ID=21812011
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9710901A BR9710901A (pt) | 1996-08-01 | 1997-07-28 | M-todo para o tratamento da doen-a bipolar |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0821955B1 (pt) |
| JP (1) | JP2000515547A (pt) |
| KR (1) | KR20000029647A (pt) |
| CN (1) | CN1226165A (pt) |
| AT (1) | ATE213413T1 (pt) |
| AU (1) | AU716972B2 (pt) |
| BR (1) | BR9710901A (pt) |
| CA (1) | CA2261802C (pt) |
| CZ (1) | CZ27299A3 (pt) |
| DE (1) | DE69710526T2 (pt) |
| DK (1) | DK0821955T3 (pt) |
| EA (1) | EA199900174A1 (pt) |
| ES (1) | ES2171838T3 (pt) |
| HU (1) | HUP9904578A2 (pt) |
| IL (1) | IL128280A0 (pt) |
| NO (1) | NO990436L (pt) |
| PL (1) | PL331407A1 (pt) |
| PT (1) | PT821955E (pt) |
| WO (1) | WO1998005324A1 (pt) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3061821B1 (en) | 2009-07-22 | 2019-07-10 | Puretech Health LLC | Compositions for treatment of disorders ameliorated by muscarinic receptor activation |
| US10265311B2 (en) | 2009-07-22 | 2019-04-23 | PureTech Health LLC | Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation |
| US20140206667A1 (en) | 2012-11-14 | 2014-07-24 | Michela Gallagher | Methods and compositions for treating schizophrenia |
| EP3856182B1 (en) | 2018-09-28 | 2025-12-24 | Karuna Therapeutics, Inc. | Compositions and methods for treating disorders ameliorated by muscarnic receptor activation |
| CN111430027B (zh) * | 2020-03-18 | 2023-04-28 | 浙江大学 | 基于肠道微生物的双相情感障碍生物标志物及其筛选应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5043345A (en) * | 1989-02-22 | 1991-08-27 | Novo Nordisk A/S | Piperidine compounds and their preparation and use |
| US5376668A (en) * | 1990-08-21 | 1994-12-27 | Novo Nordisk A/S | Heterocyclic compounds |
| ES2177581T3 (es) * | 1993-08-19 | 2002-12-16 | Novo Nordisk As | Uso de compuestos de piperidina en el tratamiento de esquizofrenia. |
| US5821371A (en) * | 1994-10-24 | 1998-10-13 | Eli Lilly And Comany | Heterocyclic compounds and their preparation and use |
| AU4139096A (en) * | 1994-10-31 | 1996-05-23 | Eli Lilly And Company | Method for treating anxiety |
| US5488056A (en) * | 1994-10-31 | 1996-01-30 | Eli Lilly And Company | Method for treating anxiety |
-
1997
- 1997-07-25 PT PT97305585T patent/PT821955E/pt unknown
- 1997-07-25 DK DK97305585T patent/DK0821955T3/da active
- 1997-07-25 DE DE69710526T patent/DE69710526T2/de not_active Expired - Lifetime
- 1997-07-25 ES ES97305585T patent/ES2171838T3/es not_active Expired - Lifetime
- 1997-07-25 AT AT97305585T patent/ATE213413T1/de active
- 1997-07-25 EP EP97305585A patent/EP0821955B1/en not_active Expired - Lifetime
- 1997-07-28 EA EA199900174A patent/EA199900174A1/ru unknown
- 1997-07-28 JP JP10508002A patent/JP2000515547A/ja not_active Ceased
- 1997-07-28 CZ CZ99272A patent/CZ27299A3/cs unknown
- 1997-07-28 IL IL12828097A patent/IL128280A0/xx unknown
- 1997-07-28 KR KR1019997000720A patent/KR20000029647A/ko not_active Withdrawn
- 1997-07-28 PL PL97331407A patent/PL331407A1/xx unknown
- 1997-07-28 WO PCT/US1997/013185 patent/WO1998005324A1/en not_active Ceased
- 1997-07-28 BR BR9710901A patent/BR9710901A/pt not_active Application Discontinuation
- 1997-07-28 CA CA002261802A patent/CA2261802C/en not_active Expired - Lifetime
- 1997-07-28 CN CN97196820A patent/CN1226165A/zh active Pending
- 1997-07-28 AU AU40468/97A patent/AU716972B2/en not_active Ceased
- 1997-07-28 HU HU9904578A patent/HUP9904578A2/hu unknown
-
1999
- 1999-01-29 NO NO990436A patent/NO990436L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATE213413T1 (de) | 2002-03-15 |
| AU716972B2 (en) | 2000-03-09 |
| CN1226165A (zh) | 1999-08-18 |
| PL331407A1 (en) | 1999-07-19 |
| WO1998005324A1 (en) | 1998-02-12 |
| CA2261802C (en) | 2006-11-07 |
| EP0821955B1 (en) | 2002-02-20 |
| EP0821955A3 (en) | 1998-04-22 |
| IL128280A0 (en) | 1999-11-30 |
| HUP9904578A2 (hu) | 2000-06-28 |
| EP0821955A2 (en) | 1998-02-04 |
| CA2261802A1 (en) | 1998-02-12 |
| NO990436D0 (no) | 1999-01-29 |
| PT821955E (pt) | 2002-07-31 |
| AU4046897A (en) | 1998-02-25 |
| CZ27299A3 (cs) | 1999-08-11 |
| EA199900174A1 (ru) | 1999-08-26 |
| KR20000029647A (ko) | 2000-05-25 |
| DK0821955T3 (da) | 2002-03-18 |
| DE69710526D1 (de) | 2002-03-28 |
| JP2000515547A (ja) | 2000-11-21 |
| ES2171838T3 (es) | 2002-09-16 |
| DE69710526T2 (de) | 2002-10-02 |
| NO990436L (no) | 1999-01-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0665013T3 (da) | Behandling af hyperproliferative karsygdomme | |
| DE69729946D1 (de) | Verwendung von cyclooxygenase-2 inhibitoren zur behandlung und verbeugung von neoplasia | |
| PT971713E (pt) | Utilizacao de inibidores da colinesterase para tratamento de desordens da atencao | |
| DE69716810D1 (de) | 2,3-Disubstituierte-(5,6)-heteroarylkondensierte-pyrimidin-4-one | |
| BR9508862A (pt) | Processo para o condicionamento de cabelos e da pele | |
| ATE152111T1 (de) | K-252a derivate | |
| ES2194960T3 (es) | N-(2-sustituido-3-(2-aminoetil)-1h-indol-5-il)-amidas como nuevos agonistas de 5-ht1f. | |
| PT627221E (pt) | Substancias antagonistas p para o tratamento de emese | |
| PT768086E (pt) | Tratamento de tinido utilizando agentes neuroprotectores | |
| IL175398A0 (en) | Steroidal compounds and pharmaceutical compositions containing them for treating oxidative stress and inflammation | |
| DK0699439T3 (da) | Behandling af sygdomme forårsaget af talgkirtellidelser med acyl-CoA-cholesterolacyltransferaseinhibitorer | |
| ES2107279T3 (es) | Diesteres de fosfato para el tratamiento de enfermedades proliferativas de la epidermis. | |
| DK0655243T3 (da) | Melatoninderivater til anvendelse ved behandling af søvnlidelser | |
| BR9710901A (pt) | M-todo para o tratamento da doen-a bipolar | |
| NO944340L (no) | Melatoninderivater for anvendelse ved behandling av desynkroniseringstilstander | |
| HUT70757A (en) | Pharmaceutical compositions for treating skin disorders | |
| DE69706195D1 (de) | Antikonvulsive derivate zur behandlung von psoriasis | |
| ATE283269T1 (de) | 5-(heteroaryl)alkyl)-3-oxo-pyrido(1,2- a)benzimidazol-4-carboxamid (pbi) derivate zur behandlung von störungen des zentralen nervensystems | |
| DK0810223T3 (da) | Adamantylsubstituerede oxindoler som farmaceutiske midler | |
| ATE61585T1 (de) | N-carboxyalcoyl-2-oxo-3-diaryl-5-6 triazine als heilmittel. | |
| ITPD960038U3 (it) | Associazione di porfirina cationica e sorgente luminosa coerente o non coerente per il trattamento di infezioni microbiche dell'endodonto e | |
| UA25791A (uk) | Спосіб коhтролю ефективhості лікуваhhя стабільhої стеhокардії |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA10 | Dismissal: dismissal - article 33 of industrial property law | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |